Elso
October 8, 2020
Entegrion’s point-of-care VCM Cascade system for measuring patient haemostasis that was developed, CE marked and still manufactured by Medtechtomarket is being successfully used by a number of the world’s leading authorities in ICU medicine for the therapy monitoring of Covid-19 critically ill patients, as reported in the 31st Annual Elso Conference (Mauro Panigada et al., Sept 2020). The system performs better than the current gold standard coagulation test in monitoring the stability and dosing of heparinised patients, and we look forward to hearing more about this ground breaking medicine.